Yong W. Park

Department Of R&D
Songnam, Republic of Korea

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 44 publications

Bromelain-cleaved hemagglutinin production from cell culture-derived influenza viruses enhances vaccine potency quantification by single radial immunodiffusion assay.

Bromelain-cleaved hemagglutinin production from cell culture-derived influenza viruses enhances vaccine potency quantification by single radial immunodiffusion assay.

Journal: Vaccine

Published: September 24, 2025

Safety and immunogenicity of a homologous booster dose of a SARS-CoV-2 recombinant protein nanoparticle vaccine (GBP510) adjuvanted with AS03: 12 months follow-up result of an open-label, nonrandomized extension of a phase 1/2 trial.

Safety and immunogenicity of a homologous booster dose of a SARS-CoV-2 recombinant protein nanoparticle vaccine (GBP510) adjuvanted with AS03: 12 months follow-up result of an open-label, nonrandomized extension of a phase 1/2 trial.

Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases

Published: July 30, 2025

Circulating Plasmacytoid Dendritic Cells Are Numerically and Functionally Deficient in Trauma Patients.

Circulating Plasmacytoid Dendritic Cells Are Numerically and Functionally Deficient in Trauma Patients.

Journal: Journal of innate immunity

Published: April 29, 2025

A Novel Flexible Fixation Method for Syndesmotic Injury.

A Novel Flexible Fixation Method for Syndesmotic Injury.

Journal: Foot & ankle international

Published: June 17, 2023

Immunogenicity and safety of SARS-CoV-2 recombinant protein nanoparticle vaccine GBP510 adjuvanted with AS03: interim results of a randomised, active-controlled, observer-blinded, phase 3 trial.

Immunogenicity and safety of SARS-CoV-2 recombinant protein nanoparticle vaccine GBP510 adjuvanted with AS03: interim results of a randomised, active-controlled, observer-blinded, phase 3 trial.

Journal: EClinicalMedicine

Published: January 26, 2023

Immunogenicity and protective efficacy of GBP510/AS03 vaccine against SARS-CoV-2 delta challenge in rhesus macaques.

Immunogenicity and protective efficacy of GBP510/AS03 vaccine against SARS-CoV-2 delta challenge in rhesus macaques.

Journal: NPJ vaccines

Published: September 05, 2022

Safety and immunogenicity of a SARS-CoV-2 recombinant protein nanoparticle vaccine (GBP510) adjuvanted with AS03: A randomised, placebo-controlled, observer-blinded phase 1/2 trial.

Safety and immunogenicity of a SARS-CoV-2 recombinant protein nanoparticle vaccine (GBP510) adjuvanted with AS03: A randomised, placebo-controlled, observer-blinded phase 1/2 trial.

Journal: EClinicalMedicine

Published: March 21, 2022

PEComa in the rectum: A case report and review of the literature on epithelioid angiomyolipoma.

PEComa in the rectum: A case report and review of the literature on epithelioid angiomyolipoma.

Journal: International journal of surgery case reports

Published: June 23, 2021

Altered distribution, activation and increased IL-17 production of mucosal-associated invariant T cells in patients with acute respiratory distress syndrome.

Altered distribution, activation and increased IL-17 production of mucosal-associated invariant T cells in patients with acute respiratory distress syndrome.

Journal: Thorax

Published: June 01, 2021

Immunization with RBD-P2 and N protects against SARS-CoV-2 in nonhuman primates.

Immunization with RBD-P2 and N protects against SARS-CoV-2 in nonhuman primates.

Journal: Science advances

Published: January 23, 2021

Correction of author's name: Atypical femoral neck fracture after prolonged bisphosphonate therapy.

Correction of author's name: Atypical femoral neck fracture after prolonged bisphosphonate therapy.

Journal: Journal of pathology and translational medicine

Published: September 10, 2020

Comparison of antigenic mutation during egg and cell passage cultivation of H3N2 influenza virus.

Comparison of antigenic mutation during egg and cell passage cultivation of H3N2 influenza virus.

Journal: Clinical and experimental vaccine research

Published: January 10, 2020

Showing 1-12 of 44

Last Updated: 09/26/2026